Background: Cancer is a major public health problem that gives an economical burden on the patient and government. The incidence of different types of cell tumors are increasing nowadays.
Introduction
CANCER is a disease of the cells in the body, it is the name that is given to a mass of cells that grows in an abnormal, unregulated way and that ultimately overwhelms a body system or organ. Cancer is currently a major cause of morbidity and mortality internationally and poses a significant burden on both patients and their families and the health care system as a whole [1, 2] .
There are several definitions of cancer survivors; we use the term "cancer survivor" to describe any person who has been diagnosed with cancer. This includes patients currently fighting cancer and those who may have become cancer free. Many survivors must cope with long-term effects of treatment as well as psychological concerns such as fear of recurrence. The terms "patient with cancer" and "survivor" are used interchangeably. It is important to note that not all individuals with a history of cancer identified with the term "cancer survivor" [3] . Chemotherapy(CT) is one of three pillars of cancer treatment along with surgical treatment and Radiotherapy (RT). CT drugs interfere with a cancer cell's ability to divide and reproduce. It differs from surgery or radiation in that it's almost always used as a systemic treatment [4] [5] [6] .
Although CT is given to kill cancer cells, it also damages normal cells and cause significant side effects. Side effects vary depending on the particular CT drug, dosage, rout of administration and patient characteristics, some people have very few side effects while others may have more. Some CT side effects can be severe enough to require hospitalization [4, 6, 7] . Many chemotherapy agents can induce pulmonary toxicity, these patterns of [8] .
Fatigue is one of the most common symptoms of cancer and its treatment, manifested in the clinic through weakness and exercise intolerance. Recent Advances: Oxidative stress, mediated by cancer or chemotherapeutic agents, is an underlying mechanism of the drug-induced toxicity. No targeted tissues, such as striated muscle, are severely affected by oxidative stress during chemotherapy. There is clinically available chemotherapy drugs that cause fatigue and oxidative stress in cancer patients, with an in-depth focus on the anthracycline doxorubicin. Doxorubicin, an effective anticancer drug, is a primary example of how chemotherapeutic agents disrupt striated muscle function through oxidative stress [9] .
There is considerable evidence that respiratory muscle training improves pulmonary function and exercise performance in healthy athletic populations. As it increases respiratory muscle strength and delays respiratory muscle fatigue and the onset of breathlessness. Respiratory muscle training has proven to be beneficial for respiratory function in patients withchronic diseases [10] .
Inspiratory muscle training applies a load to the diaphragm and accessory inspiratory muscles to increase their strength and endurance [11] .
Patients and Methods
Forty male patients on chemotherapy from at least one cycle and their ages were ranged from 30 to 50 years. The patients were selected from National Cancer Institute, Cairo (inpatient ward). Exclusion criteria: Lung cancer, history of any pulmonary disease, metastasis of lung, ribs, mediastinal structure, pulmonary pathology (e.g. acute respiratory distress syndrome or exacerbation of chronic obstructive pulmonary disease), ruptured eardrum or any other condition of the ear, severe bronchospasm, patients with worsening heart failure signs and symptoms, bed-ridden patients.
Procedures of the study: -Evaluation procedures:
Spirometric tests: Spirometric measurements (FVC), (FEV1) and (FEV1/FVC) ratios. The best value is obtained from at least three efforts and measured at 3min intervals.
2min walk test: Each patient was asked to cover as much ground as possible over 2 minutes. Continuous walking if possible, and to be concerned if he needed to slow down or stop to rest.
Therapeutic procedures: -Threshold inspiratory muscle training (Hs730-
Eu-010/USA) : (Group A) the patients were starting breathing at a resistance equal to 30% of their Maximal Inspiratory Pressure (MIP), measured at baseline [12] . Session duration: 15 minutes [13] , frequency: Each session was performed each morning for 15 minutes [12] .
-Incrementing the training load: The resistance was increased incrementally, based on the rate of Perceived Exertion (RPE) scored by the patient on the modified Borg Scale. The acceptable level of exertion in this study was level 4. If the RPE was less than 5, the resistance of the inspiratory threshold trainer was increased incrementally by 2cm H2O. The resistance was not change if the level of perceived exertion was rated from 6 to 8, and the resistance was decreased by 1 to 2cm H2O if the level of perceived exertion was rated 9 or 10 [13] . Then the load was increased rapidly over the first 7 days up to 60-80% of baseline MIP [14] .
-Eventually, the patients received respiratory muscle training by threshold inspiratory muscle training each morning for 4 weeks. 
Results

Subjects demographic data:
There was no significance difference between both groups in the mean age, weight, height, and BMI (p>0.05) as shown in (Table 1) .
FVC, FEV1 and FEV1/FVC ratio: Pre treatment mean values of FVC, FEV1 and FEV1/FVC ratio of both groups (A and B):
FVC: The mean difference between both groups was -0.22 L. There was no significant difference pre treatment in the FVC between the group A and B (p=0.65) ( Table 2) .
FEV1:
The mean difference between both groups was -0.09L. There was no significant difference pre treatment in the FEV 1 between the group A and B (p=0.8) ( Table 2) .
FEV1/FVC ratio:
The mean difference between both groups was -0.07L. There was no significant difference pre treatment in the FEV1/FVC ratio between the group A and B (p=0.98) ( Table 2) .
Post-treatment mean values of FVC, FEV1 and FEV1/FVC ratio of both groups (A and B):
FVC: The mean difference between both groups was 2.02L. There was a significant increase posttreatment by 33.44% in the FVC of group A compared with that of group B ( p=0.0001) ( Table 3) .
FEV1:
The mean difference between both groups was 1.67 L. There was a significant increase post-treatment by 34.52% in the FEV1 of group A compared with that of group B ( p=0.0001) ( Table 3) .
FEV1/FVC ratio:
The mean difference between both groups was -1.34%. There was no significant difference post-treatment in the FEV1/FVC ratio between the group A and B (p=0.68) ( Table 3) .
2min walk test distance:
Pre-treatment mean values of 2min walk test distance of both groups (A and B): The mean difference between both groups was 1.66 meter. There was no significant difference pre-treatment in the 2min walk test distance between the group A and B (p=0.87) ( Table 4 ).
Post-treatment mean values of 2min walk test distance of both groups (group A and B):
The mean difference between both groups was 39.25 meter. There was a significant increase post-treatment by 17.29% in the 2min walk test distance of the group A compared with that of the group B ( p=0.01). (Table 5 ). 
Discussion
The result of this study were supported by Pfalzer et al., 2008 [15] , who studied the effect of A 10-week inspiratory muscle training program using IMT device on lower-extremity mobility in people with Multiple Sclerosis (MS) which found significantly increase in inspiratory muscle strength, timed static standing balance scores, and a trend toward increase in distance walked on the 6MW test in ambulatory individuals with mild-tomoderate MS.
Physical and functional effects of cancer and its treatments include diminished cardiovascular function, reduced pulmonary function, decreased strength, deterioration of lean body tissue, weight change, difficulty sleeping, fatigue, nausea and vomiting, and pain [16] . Moreover, this study was supported by Stephanie et al., 2018 [17] , who showed that high-intensity IMT was set at 80% of maximal effort which resulted in increased Maximum Inspiratory Pressure [MIP] and Sustained Maximum Inspiratory Pressure [SMIP], lung volumes, work capacity, and power output in individuals who were healthy, whereas IMT at 60% of maximal effort increased work capacity and power output only. Inspiratory muscle training intensities lower than 40% of maximal effort did not translate into quantitative functional outcomes. Mello et al., 2012 [18] , stated that a simple, inexpensive, home-based in IMT program resulted in clinically relevant increments of maximal functional capacity, associated with a reduction in Muscle Sympathetic Nerve Activity (MSNA) and improvement in the quality of life. Moreover, our results show that respiratory muscle training improves exercise intolerance, neurovascular control, and cardiac sympathetic and parasympathetic regulation in patients with Chronic Heart Failure (CHF).
Conversely, Valkenet et al., 2016 [19] , study showed that pre-operative inspiratory muscle training decreased incidence of pneumonia and length of hospital stay in trial group but did not find any improvements in functional capacity due to the preoperative home-based inspiratory muscle training program.
Foden et al., 2010 [20] , study showed that in the IMT group, both MIP and maximum expiratory pressure (17% and 23%, respectively; p (0.03) were improved. Similar improvements were noted for the sham-IMT group with 23% and 33% from baseline for MIP and maximum expiratory pressure, respectively p (0.03). There were no significant changes in pulmonary function at rest and any of the performance parameters associated with the repetitive sprint test (sprint and recovery times, peak heart rate and peak blood lactate concentration). Reported experiences of using the IMT train-ing device suggested "less breathlessness" and "less tightness in the chest during the training". Which concluded that although there was no improvement in sprint performance, an improved respiratory muscle function and quality of life were reported by participants in both the IMT and sham-IMT groups.
Finally it can be concluded that the improvement in ventilatory functions and functional capacity in patients on chemotherapy due to IMT in group A by increasing inspiratory muscle strength which overcome fatigue and cachexia (form of the side effects of chemotherapy).
Conclusion:
According to the results, it can be concluded that there is a significant effect on functional capacity which appear in 2min walk test distance results and significant increase in ventilatory function (FVC and FEV1) which overcome the chemotherapy and cancer related fatigue. Although there was no significant changes in FEV1/FVC ratio.
